Follow
Eswar Shankar
Eswar Shankar
Verified email at osumc.edu
Title
Cited by
Cited by
Year
Chamomile: A herbal medicine of the past with a bright future
JK Srivastava, E Shankar, S Gupta
Molecular medicine reports 3 (6), 895-901, 2010
10062010
Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges
E Shankar, R Kanwal, M Candamo, S Gupta
Seminars in cancer biology 40, 82-99, 2016
1542016
Plant flavone apigenin: an emerging anticancer agent
E Shankar, A Goel, K Gupta, S Gupta
Current pharmacology reports 3, 423-446, 2017
1462017
Suppression of NF-κB and NF-κB-regulated gene expression by apigenin through IκBα and IKK pathway in TRAMP mice
S Shukla, E Shankar, P Fu, GT MacLennan, S Gupta
Plos one 10 (9), e0138710, 2015
932015
Apigenin blocks IKKα activation and suppresses prostate cancer progression
S Shukla, R Kanwal, E Shankar, M Datt, MR Chance, P Fu, ...
Oncotarget 6 (31), 31216, 2015
902015
Dopaminergic regulation of glucose‐induced insulin secretion through dopamine D2 receptors in the pancreatic islets in vitro
E Shankar, KT Santhosh, CS Paulose
IUBMB life 58 (3), 157-163, 2006
852006
High‐fat diet increases NF‐κB signaling in the prostate of reporter mice
EV Vykhovanets, E Shankar, OV Vykhovanets, S Shukla, S Gupta
The Prostate 71 (2), 147-156, 2011
782011
High‐fat diet activates pro‐inflammatory response in the prostate through association of Stat‐3 and NF‐κB
E Shankar, EV Vykhovanets, OV Vykhovanets, GT MacLennan, R Singh, ...
The Prostate 72 (3), 233-243, 2012
722012
Androgen receptor‐related diseases: what do we know?
GC Shukla, AR Plaga, E Shankar, S Gupta
Andrology 4 (3), 366-381, 2016
702016
Downregulation of Bid is associated with PKCɛ-mediated TRAIL resistance
U Sivaprasad, E Shankar, A Basu
Cell Death & Differentiation 14 (4), 851-860, 2007
702007
Betulinic acid-mediated apoptosis in human prostate cancer cells involves p53 and nuclear factor-kappa B (NF-κB) pathways
E Shankar, A Zhang, D Franco, S Gupta
Molecules 22 (2), 264, 2017
582017
Inflammatory signaling involved in high-fat diet induced prostate diseases
E Shankar, N Bhaskaran, GT MacLennan, G Liu, F Daneshgari, S Gupta
Journal of urology and research 2 (1), 2015
572015
Green tea–induced epigenetic reactivation of tissue inhibitor of matrix metalloproteinase‐3 suppresses prostate cancer progression through histone‐modifying enzymes
G Deb, E Shankar, VS Thakur, LE Ponsky, DR Bodner, P Fu, S Gupta
Molecular carcinogenesis 58 (7), 1194-1207, 2019
562019
Simultaneous detection of oral pathogens in subgingival plaque and prostatic fluid of men with periodontal and prostatic diseases
J Estemalik, C Demko, NF Bissada, N Joshi, D Bodner, E Shankar, ...
Journal of periodontology 88 (9), 823-829, 2017
542017
Protein kinase Cɛ confers resistance of MCF-7 cells to TRAIL by Akt-dependent activation of Hdm2 and downregulation of p53
E Shankar, U Sivaprasad, A Basu
Oncogene 27 (28), 3957-3966, 2008
542008
Oxidative stress and antioxidant status in high-risk prostate cancer subjects
S Shukla, JK Srivastava, E Shankar, R Kanwal, A Nawab, H Sharma, ...
Diagnostics 10 (3), 126, 2020
462020
Protein kinase C-ε protects MCF-7 cells from TNF-mediated cell death by inhibiting Bax translocation
D Lu, U Sivaprasad, J Huang, E Shankar, S Morrow, A Basu
Apoptosis 12, 1893-1900, 2007
462007
Critical role of a survivin/TGF-β/mTORC1 axis in IGF-I-mediated growth of prostate epithelial cells
K Song, E Shankar, J Yang, KL Bane, R Wahdan-Alaswad, D Danielpour
PloS one 8 (5), e61896, 2013
442013
Statin use in prostate cancer: an update
MA Babcook, A Joshi, JA Montellano, E Shankar, S Gupta
Nutrition and metabolic insights 9, NMI. S38362, 2016
422016
MiR-644a disrupts oncogenic transformation and warburg effect by direct modulation of multiple genes of tumor-promoting pathways
JS Ebron, E Shankar, J Singh, K Sikand, CM Weyman, S Gupta, ...
Cancer Research 79 (8), 1844-1856, 2019
402019
The system can't perform the operation now. Try again later.
Articles 1–20